Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Innovate UK selects PBD Biotech, with its rapid test for mycobacteria, for Canada trade mission

PBD Biotech has been selected by Innovate UK as one of 15 highly innovative agritech companies to join its Global Business Accelerator Programme trade mission to Canada, 18 - 22 June 2018.
  • May 7, 2018
  • International
  • Canada, international
Dr Berwyn Clarke at REAP
Dr Berwyn Clarke at Agri-Tech East's REAP conference

During the visit, PBD Biotech announced it will be expanding to Saskatoon to begin trial studies of its diagnostic technology for infections in animals.

The start-up has developed a novel diagnostic called Actiphage®, which provides a highly specific and sensitive assay for the cost-effective detection of mycobacterial disease in blood and milk.

Mycobacteria are a cause of a number of diseases in cattle and other species, such as bovine TB and Johne’s Disease. The assay has been accepted as part of UK Government protocol for Exceptional private use on herds suffering persistent TB breakdowns in England.

As Actiphage can distinguish between viable and non-viable organisms; it can reliably differentiate between animals carrying live infectious organisms and those that have been specifically vaccinated. As such it has the potential to become a significant tool in the detection and control of tuberculosis in animals and humans. It also has application in food safety and public health.

Innovate UK, supported by the Enterprise Europe Network, is delivering the Global Business Accelerator Programme, a fully-funded series of country visits for highly innovative businesses in selected technology sectors. The Programme’s objective is to enable companies to build strong strategic partnerships and bilateral collaborations.

If you would like to meet with PBD Biotech or any of the other delegates, please register via the Global Business Accelerator Programme website.

Share:

Related posts

Loading...
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as Director of Operations in North America, to advise on regulatory affairs and provide technical and customer support.
Tom Kellner

PBD Biotech expands its North American operations

January 27, 2022
PBD Biotech is expanding its North American team. Tuberculosis (TB) and Johne’s Disease expert Tom Kellner has been appointed as...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss of production. Now, advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss...
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have been selected to join the first Missouri Agri-Tech Connect Programme this week (23 – 27 February 2020).
Missouri

Bovine TB test developers selected for USA agri-food delegation

February 24, 2020
PBD Biotech, developers of a rapid new test for bovine TB, is one of seven UK agri-tech companies to have...
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd Bovine Brucellosis and Tuberculosis Eradication Campaign (BTEC) Forum on 27 and 28 November 2019.
Fiji

27-28 November 2019

PBD Biotech invited to speak at Fiji Bovine TB Eradication Forum

November 7, 2019
Dr Ben Swift, co-founder of PBD Biotech, has been invited by Fiji’s Ministry of Agriculture to speak at its 2nd...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More